Request for Information on Research Opportunities and Operational Activities Related to the NIH Strategic Plan To Advance Research on the Health and Well-Being of Sexual & Gender Minorities Fiscal Years 2021-2025, 54224-54225 [2021-21319]
Download as PDF
<![CDATA[
54224
Federal Register / Vol. 86, No. 187 / Thursday, September 30, 2021 / Notices
by emailing PACHA@hhs.gov by close of
business Wednesday, November 24,
2021. The meeting agenda will be
posted on the PACHA page on HIV.gov
at https://www.hiv.gov/federalresponse/pacha/about-pacha prior to
the meeting.
The meeting will be held on
Monday, November, 15 and Wednesday,
November, 17, 2021 from 1:00–5:00 p.m.
(ET) on both days. This meeting will be
conducted utilizing virtual technology.
DATES:
Instructions on attending
this meeting virtually will be posted one
week prior to the meeting at: https://
www.hiv.gov/federal-response/pacha/
about-pacha.
ADDRESSES:
Ms.
Caroline Talev, MPA, Public Health
Analyst, Presidential Advisory Council
on HIV/AIDS, 330 C Street SW, Room
L609A, Washington, DC 20024; (202)
795–7622 or PACHA@hhs.gov.
Additional information can be obtained
by accessing the Council’s page on the
HIV.gov site at www.hiv.gov/pacha.
FOR FURTHER INFORMATION CONTACT:
PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996 and is currently operating
under the authority given in Executive
Order 13889, dated September 27, 2019.
The Council was established to provide
advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to promote effective
prevention and care of HIV infection
and AIDS. The functions of the Council
are solely advisory in nature.
The Council consists of not more than
25 members. Council members are
selected from prominent community
leaders with particular expertise in, or
knowledge of, matters concerning HIV
and AIDS, public health, global health,
philanthropy, marketing or business, as
well as other national leaders held in
high esteem from other sectors of
society. Council members are appointed
by the Secretary or designee, in
consultation with the White House.
LOTTER on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
Dated: September 23, 2021.
Caroline Talev,
Management Analyst, Office of Infectious
Disease and HIV/AIDS Policy, Alternate
Designated Federal Officer, Presidential
Advisory Council on HIV/AIDS, Office of the
Assistant Secretary for Health, Department
of Health and Human Services.
[FR Doc. 2021–21275 Filed 9–29–21; 8:45 am]
BILLING CODE 4150–43–P
VerDate Sep<11>2014
18:15 Sep 29, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on Research
Opportunities and Operational
Activities Related to the NIH Strategic
Plan To Advance Research on the
Health and Well-Being of Sexual &
Gender Minorities Fiscal Years 2021–
2025
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
Through this Request for
Information (RFI), the Sexual & Gender
Minority Research Office (SGMRO) in
the Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI), Office of the Director (OD),
National Institutes of Health (NIH),
invites feedback from stakeholders
throughout the scientific research
community, clinical practice
communities, patient and family
advocates, scientific or professional
organizations, federal partners, internal
NIH stakeholders, and other interested
constituents on research opportunities
and operational activities related to the
NIH Strategic Plan to Advance Research
on the Health and Well-Being of Sexual
and Gender Minorities fiscal years (FY)
2021–2025. The goal of this request for
information is to provide SGM focused
organizations, researchers, non-profits,
and community members an
opportunity to identify potential
research opportunities and operational
activities related to the NIH mission.
DATES: The SGMRO’s Request for
Information is open for public comment
for a period of 8 weeks. Comments must
be received on or before COB (5:00 p.m.
ET) December 3, 2021, to ensure
consideration. After the public comment
period has closed, the comments
received by SGMRO will be considered
in a timely manner for further
implementation of the NIH Strategic
Plan to Advance Research on the Health
and Well-Being of Sexual and Gender
Minorities FY 2021–2025. Comments
will be summarized and posted to the
SGMRO website.
ADDRESSES: Please see the NIH Strategic
Plan to Advance Research on the Health
and Well-Being of Sexual and Gender
Minorities FY 2021–2025. Comments
must be received by email at SGMRO@
nih.gov. Please include Request for
Information in the subject line.
FOR FURTHER INFORMATION CONTACT:
Irene Avila, Ph.D., Assistant Director,
Sexual & Gender Minority Research
SUMMARY:
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Office (SGMRO), irene.avila@nih.gov,
(301) 594–9701.
SUPPLEMENTARY INFORMATION:
Background: ‘‘Sexual and gender
minority’’ is an overarching term that
includes, but is not limited to,
individuals who identify as lesbian, gay,
bisexual, asexual, transgender, twospirit, queer, and/or intersex.
Individuals with same-sex or -gender
attractions or behaviors and those with
a difference in sex development are also
included. These populations also
encompass those who do not selfidentify with one of these terms but
whose sexual orientation, gender
identity or expression, or reproductive
development is characterized by nonbinary constructs of sexual orientation,
gender, and/or sex.
The Sexual and Gender Minority
Research Office (SGMRO) coordinates
sexual and gender minority (SGM)–
related research and activities by
working directly with the NIH
Institutes, Centers, and Offices. The
Office was officially established in
September 2015 within the NIH
Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI) in the Office of the Director.
This Federal Register notice is in
accordance with the 21st Century Cures
Act, NIH is required to regularly update
their strategic plans. In September 2020,
SGMRO posted the NIH Strategic Plan
to Advance Research on the Health and
Well-Being of Sexual and Gender
Minorities FY 2021–2025. The current
strategic plan has provided NIH with a
framework to improve the health of
SGM populations through increased
research and support of scientists
conducting SGM-relevant research.
Request for Comments on Research
Opportunities and Operational
Activities related to the NIH Strategic
Plan to Advance Research on the Health
and Well-being of Sexual and Gender
Minorities FY 2021–2025: The NIH has
developed a strategic plan to advance
SGM research over the next five years.
The SGMRO invites input from
stakeholders throughout the scientific
research community, clinical practice
communities, patient and family
advocates, scientific or professional
organizations, federal partners, internal
NIH stakeholders, and other interested
members of the public on potential
research opportunities and operational
activities related to this plan and the
NIH mission. This input is valuable, and
the community’s time and consideration
are appreciated.
The SGMRO is invested in increasing
SGM-related health research and
identifying high-priority research
E:\FR\FM\30SEN1.SGM
30SEN1
Federal Register / Vol. 86, No. 187 / Thursday, September 30, 2021 / Notices
opportunities and operational activities
related to SGM health.
The FY 2021–2025 strategic plan
includes the following four scientific
themes and research opportunities:
1. Clinical research
2. Social and behavioral research
3. Research in chronic diseases and
comorbidities
4. Methods and measurement research
Overarching considerations for SGM
research extend to all scientific research
goal areas to help foster a deeper
understanding of SGM health
disparities. Key examples of these
overarching considerations for SGM
research include intersectionality, life
situations, aging, SGM subpopulations,
and relevant research frameworks.
The FY 2021–2025 strategic plan
includes the following four operational
goals:
LOTTER on DSK11XQN23PROD with NOTICES1
1. Advance rigorous research on the health
of SGM populations in both the extramural
and intramural research communities;
2. Expand SGM health research by
fostering partnerships and collaborations
with a strategic array of internal and external
stakeholders;
3. Foster a highly skilled and diverse
workforce in SGM health research; and
4. Encourage data collection related to
SGM populations in research and the
biomedical research workforce.
The populations considered under the
SGM umbrella term are inclusive and
capture all individuals and populations
who do not self-identify with binary
constructs of sexual orientation, gender,
and/or sex. Examples of such
populations may include intersex
individuals or individuals with
differences or disorders of sex
development (DSD), Two-Spirit people,
transgender and gender-expansive
people, bisexual people, and
individuals whose gender identity falls
within the full spectrum of gender.
To advance NIH priorities in SGM
health research, SGMRO requests input
from SGM health researchers and
related communities on potential
research opportunities related to the
goals of the FY 2021–2025 strategic
plan.
Responses to this RFI are voluntary.
Do not include any proprietary,
classified, confidential, trade secret, or
sensitive information in your response.
The responses will be reviewed by NIH
staff, and individual feedback will not
be provided to any responder. The
Government will use the information
submitted in response to this RFI at its
discretion. The Government reserves the
right to use any submitted information
on public NIH websites; in reports; in
summaries of the state of the science; in
any possible resultant solicitation(s),
VerDate Sep<11>2014
18:15 Sep 29, 2021
Jkt 253001
grant(s), or cooperative agreement(s); or
in the development of future funding
opportunity announcements.
This RFI is for information and
planning purposes only and should not
be construed as a solicitation for
applications or proposals, or as an
obligation in any way on the part of the
United States Federal Government, NIH,
or individual NIH Institutes, Centers,
and Offices to provide support for any
ideas identified in response to it. The
federal government will not pay for the
preparation of any information
submitted or for the Government’s use
of such information.
No basis for claims against the U.S.
Government shall arise as a result of a
response to this RFI or from the
Government’s use of such information.
Additionally, the Government cannot
guarantee the confidentiality of the
information provided.
Dated: September 24, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2021–21319 Filed 9–29–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Clinical Center; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors of the NIH Clinical Center.
The meeting will be closed to the public
as indicated below in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual grant
applications conducted by the
CLINICAL CENTER, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors of the NIH Clinical Center.
Date: October 18, 2021.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate
Department of Laboratory Medicine and
interviews.
Place: Clinical Center, 10 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Date: October 19, 2021.
Time: 10:00 a.m. to 12:30 p.m.
Frm 00077
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate
Department of Laboratory Medicine and
interviews.
Place: Clinical Center, 10 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ronald Neumann, MD,
Senior Investigation, Clinical Center,
National Institutes of Health, 10 Center Drive,
Bethesda, MD 20892, 301–496–6455,
rneumann@cc.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Dated: September 24, 2021.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2021–21204 Filed 9–29–21; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
PO 00000
54225
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Mexico Textile and Apparel Imports
Approved for the Electronic
Certification System (eCERT)
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This document announces
that the certification requirement for
certain imports of textile and apparel
goods from the United Mexican States
(Mexico) that are eligible for preferential
tariff treatment under a tariff preference
level (TPL) will be accomplished
through the Electronic Certification
System (eCERT). Specified quantities of
certain textile and apparel imports from
Mexico that are eligible for preferential
tariff treatment under a TPL must have
a valid certificate of eligibility with a
corresponding eCERT transmission in
order for an importer to claim the
preferential duty rate. As the Agreement
Between the United States of America,
the United Mexican States and Canada
SUMMARY:
E:\FR\FM\30SEN1.SGM
30SEN1
]]>Agencies
[Federal Register Volume 86, Number 187 (Thursday, September 30, 2021)]
[Notices]
[Pages 54224-54225]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21319]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information on Research Opportunities and Operational
Activities Related to the NIH Strategic Plan To Advance Research on the
Health and Well-Being of Sexual & Gender Minorities Fiscal Years 2021-
2025
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Through this Request for Information (RFI), the Sexual &
Gender Minority Research Office (SGMRO) in the Division of Program
Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of
the Director (OD), National Institutes of Health (NIH), invites
feedback from stakeholders throughout the scientific research
community, clinical practice communities, patient and family advocates,
scientific or professional organizations, federal partners, internal
NIH stakeholders, and other interested constituents on research
opportunities and operational activities related to the NIH Strategic
Plan to Advance Research on the Health and Well-Being of Sexual and
Gender Minorities fiscal years (FY) 2021-2025. The goal of this request
for information is to provide SGM focused organizations, researchers,
non-profits, and community members an opportunity to identify potential
research opportunities and operational activities related to the NIH
mission.
DATES: The SGMRO's Request for Information is open for public comment
for a period of 8 weeks. Comments must be received on or before COB
(5:00 p.m. ET) December 3, 2021, to ensure consideration. After the
public comment period has closed, the comments received by SGMRO will
be considered in a timely manner for further implementation of the NIH
Strategic Plan to Advance Research on the Health and Well-Being of
Sexual and Gender Minorities FY 2021-2025. Comments will be summarized
and posted to the SGMRO website.
ADDRESSES: Please see the NIH Strategic Plan to Advance Research on the
Health and Well-Being of Sexual and Gender Minorities FY 2021-2025.
Comments must be received by email at [email protected]. Please include
Request for Information in the subject line.
FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant
Director, Sexual & Gender Minority Research Office (SGMRO),
[email protected], (301) 594-9701.
SUPPLEMENTARY INFORMATION: Background: ``Sexual and gender minority''
is an overarching term that includes, but is not limited to,
individuals who identify as lesbian, gay, bisexual, asexual,
transgender, two-spirit, queer, and/or intersex. Individuals with same-
sex or -gender attractions or behaviors and those with a difference in
sex development are also included. These populations also encompass
those who do not self-identify with one of these terms but whose sexual
orientation, gender identity or expression, or reproductive development
is characterized by non-binary constructs of sexual orientation,
gender, and/or sex.
The Sexual and Gender Minority Research Office (SGMRO) coordinates
sexual and gender minority (SGM)-related research and activities by
working directly with the NIH Institutes, Centers, and Offices. The
Office was officially established in September 2015 within the NIH
Division of Program Coordination, Planning, and Strategic Initiatives
(DPCPSI) in the Office of the Director.
This Federal Register notice is in accordance with the 21st Century
Cures Act, NIH is required to regularly update their strategic plans.
In September 2020, SGMRO posted the NIH Strategic Plan to Advance
Research on the Health and Well-Being of Sexual and Gender Minorities
FY 2021-2025. The current strategic plan has provided NIH with a
framework to improve the health of SGM populations through increased
research and support of scientists conducting SGM-relevant research.
Request for Comments on Research Opportunities and Operational
Activities related to the NIH Strategic Plan to Advance Research on the
Health and Well-being of Sexual and Gender Minorities FY 2021-2025: The
NIH has developed a strategic plan to advance SGM research over the
next five years. The SGMRO invites input from stakeholders throughout
the scientific research community, clinical practice communities,
patient and family advocates, scientific or professional organizations,
federal partners, internal NIH stakeholders, and other interested
members of the public on potential research opportunities and
operational activities related to this plan and the NIH mission. This
input is valuable, and the community's time and consideration are
appreciated.
The SGMRO is invested in increasing SGM-related health research and
identifying high-priority research
[[Page 54225]]
opportunities and operational activities related to SGM health.
The FY 2021-2025 strategic plan includes the following four
scientific themes and research opportunities:
1. Clinical research
2. Social and behavioral research
3. Research in chronic diseases and comorbidities
4. Methods and measurement research
Overarching considerations for SGM research extend to all
scientific research goal areas to help foster a deeper understanding of
SGM health disparities. Key examples of these overarching
considerations for SGM research include intersectionality, life
situations, aging, SGM subpopulations, and relevant research
frameworks.
The FY 2021-2025 strategic plan includes the following four
operational goals:
1. Advance rigorous research on the health of SGM populations in
both the extramural and intramural research communities;
2. Expand SGM health research by fostering partnerships and
collaborations with a strategic array of internal and external
stakeholders;
3. Foster a highly skilled and diverse workforce in SGM health
research; and
4. Encourage data collection related to SGM populations in
research and the biomedical research workforce.
The populations considered under the SGM umbrella term are
inclusive and capture all individuals and populations who do not self-
identify with binary constructs of sexual orientation, gender, and/or
sex. Examples of such populations may include intersex individuals or
individuals with differences or disorders of sex development (DSD),
Two-Spirit people, transgender and gender-expansive people, bisexual
people, and individuals whose gender identity falls within the full
spectrum of gender.
To advance NIH priorities in SGM health research, SGMRO requests
input from SGM health researchers and related communities on potential
research opportunities related to the goals of the FY 2021-2025
strategic plan.
Responses to this RFI are voluntary. Do not include any
proprietary, classified, confidential, trade secret, or sensitive
information in your response. The responses will be reviewed by NIH
staff, and individual feedback will not be provided to any responder.
The Government will use the information submitted in response to this
RFI at its discretion. The Government reserves the right to use any
submitted information on public NIH websites; in reports; in summaries
of the state of the science; in any possible resultant solicitation(s),
grant(s), or cooperative agreement(s); or in the development of future
funding opportunity announcements.
This RFI is for information and planning purposes only and should
not be construed as a solicitation for applications or proposals, or as
an obligation in any way on the part of the United States Federal
Government, NIH, or individual NIH Institutes, Centers, and Offices to
provide support for any ideas identified in response to it. The federal
government will not pay for the preparation of any information
submitted or for the Government's use of such information.
No basis for claims against the U.S. Government shall arise as a
result of a response to this RFI or from the Government's use of such
information. Additionally, the Government cannot guarantee the
confidentiality of the information provided.
Dated: September 24, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-21319 Filed 9-29-21; 8:45 am]
BILLING CODE 4140-01-P
